Our ‘Speaking of Science’ guest this month was Dr. John Erickson of the Maine Medical Center and Tufts University School of Medicine, who explored GLP-1 diabetes drugs like Ozempic, Trulicity, Rybelsus, and others, which are being used for weight loss.
About Dr. John Erickson
John Erickson, MD FACP has been one of the Associate Program Directors for the Maine Medical Center Internal Medicine Residency Program for over 10 years, and a teaching attending for the inpatient medical service and resident clinic since 1990. He continues to practice general internal medicine with InterMed and his academic interests include bedside teaching, the use of simulation for communication, the development and optimization of evaluation systems and strategies to facilitate learning along the continuum of an individual’s career.
Pivotal in the development of the Hospitalist Track, he developed and leads the Coaching Program as well as supervising the Morbidity and Mortality series for medical residents. As an Assistant Clinical Professor for the Tufts University School of Medicine, he serves as a facilitator for the “Healer’s Art” course, has done community advising for first year students and continues to lead 3rd and 4th year sessions during their medicine core lecture series. He is immediate past Governor for the Maine Chapter of the American College of Physicians, which provided an incredible opportunity to meet and collaborate with internists across Maine and around the world.
